10.08.2020 • News

Johnson Matthey Wins China Methanol Contract

Johnson Matthey has won a contract to build a third methanol synthesis plant for China’s Ningxia Baofeng Energy at its coal-to-olefins complex near Yinchuan in Ningxia province.

The unit will have a capacity of 7,200 t/d, making it the largest single train methanol plant in the world, Johnson Matthey said. The facility is bigger than Ningxia’s second plant of 6,600 t/d  that started up in May 2020, which followed  a 4,450 t/d methanol synthesis plant that was commissioned in 2014.

Under the terms of this latest agreement, Johnson Matthey will license technology and supply associated engineering, catalyst and equipment, provide technical review services as well as commissioning assistance.

The value of the contract was not disclosed.

First Russia license

The UK-based technology firm has also announced that its combined reforming methanol technology has been chosen by JSC Technoleasing for a 3,000 t/d plant in Skovorodino, Russia.

Johnson Matthey will supply a license for the plant, which will also include its new Advanced Series Loop technology that uses a synthesis loop arrangement together with existing reactor technology to significantly improve natural gas efficiency.

Pending a final investment decision by Technoleasing, Johnson Matthey said this will be its first licensed methanol plant in Russia using the combined reforming and Advanced Series Loop technology.

Johnson Matthey has won a contract to build a third methanol plant for...
Johnson Matthey has won a contract to build a third methanol plant for China’s Ningxia Baofeng Energy at its coal-to-olefins complex near Yinchuan in Ningxia province. The unit will have a capacity of 7,200 t/d, making it the largest single train methanol plant in the world. (c) davidburtonfuse /gettyimages

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.